{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:42:15Z","timestamp":1777448535156,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ijcard.2015.07.080","type":"journal-article","created":{"date-parts":[[2015,8,16]],"date-time":"2015-08-16T21:15:14Z","timestamp":1439759714000},"page":"499-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study"],"prefix":"10.1016","volume":"201","author":[{"given":"Andrew M.","family":"Tonkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Blankenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Colquhoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Funke-Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Hague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony C.","family":"Keech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Nestel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter L.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malcolm","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey D.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Simes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.07.080_bb0005","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.109.901413","article-title":"Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MOnica Study, Risk, Genetics, Archiving, and Monograph (MORGAM) biomarker project","volume":"121","author":"Blankenberg","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.07.080_bb0010","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa0707064","article-title":"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes","volume":"358","author":"Zethelius","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.105.590927","article-title":"Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study","volume":"114","author":"Blankenberg","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.07.080_bb0020","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","article-title":"A sensitive cardiac troponin T assay in stable coronary artery disease","volume":"361","author":"Omland","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0025","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1161\/CIRCULATIONAHA.112.129437","article-title":"Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study","volume":"126","author":"Wang","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.07.080_bb0030","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1001\/jama.2010.1708","article-title":"Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults","volume":"304","author":"deFilippi","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2015.07.080_bb0035","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa0900428","article-title":"Early diagnosis of myocardial infarction with sensitive cardiac troponin assays","volume":"361","author":"Reichlin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","article-title":"Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure","volume":"347","author":"Maisel","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0045","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study","volume":"339","author":"LIPID Study Group","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(01)01360-2","article-title":"Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study","volume":"38","author":"Marschner","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0055","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/01.CIR.0000160924.73417.26","article-title":"White blood cell count predicts reduction in coronary heart disease mortality with pravastatin","volume":"111","author":"Stewart","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.07.080_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.ijcard.2015.07.080_bb0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat. Med."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0070","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jacc.2013.08.1643","article-title":"Association of contemporary sensitive troponin I levels at baseline and change at 1year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID study","volume":"63","author":"White","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0075","doi-asserted-by":"crossref","first-page":"e000360","DOI":"10.1161\/JAHA.113.000360","article-title":"Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin results from the Long-Term Intervention with Pravastatin in Ischemic Disease study","volume":"2","author":"White","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0080","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1161\/ATVBAHA.113.302479","article-title":"Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease","volume":"33","author":"Nestel","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0085","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ijcard.2014.01.064","article-title":"Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study","volume":"172","author":"Funke-Kaiser","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0090","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1056\/NEJMoa055373","article-title":"Multiple biomarkers for the prediction of first major cardiovascular events and death","volume":"355","author":"Wang","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0095","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/eurheartj\/ehq322","article-title":"Multiple marker approach to risk stratification in patients with stable coronary artery disease","volume":"31","author":"Schnabel","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/CIRCULATIONAHA.111.063842","article-title":"Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease","volume":"125","author":"Sabatine","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.07.080_bb0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"Koenig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.07.080_bb0110","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/01.CIR.0000116763.91992.F1","article-title":"Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk In Communities (ARIC) study","volume":"109","author":"Ballantyne","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.07.080_bb0120","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa001066","article-title":"Lipoprotein(a), vascular disease, and mortality in the elderly","volume":"349","author":"Ariyo","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0125","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jacc.2005.09.039","article-title":"B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the Atherogene study","volume":"47","author":"Schnabel","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0130","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0135","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.jacc.2011.01.029","article-title":"Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis?","volume":"57","author":"White","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"Pencina","year":"2011","journal-title":"Stat. Med."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0145","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1056\/NEJMoa1315878","article-title":"Darapladib for preventing ischemic events in stable coronary heart disease","volume":"370","author":"STABILITY Investigators","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.07.080_bb0150","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacc.2012.12.023","article-title":"Extreme lipoprotein(a) levels and risk of myocardial infarction","volume":"61","author":"Kamstrup","year":"2013","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315302138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315302138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T14:42:17Z","timestamp":1668609737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315302138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":30,"alternative-id":["S0167527315302138"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.07.080","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.07.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}